Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J team marks another setback on depression as midstage study flops
J&J team marks another setback on depression as midstage study flops
J&J team marks another setback on depression as midstage study flops
Submitted by
admin
on February 10, 2014 - 5:46pm
Source:
Fierce Biotech
News Tags:
JNJ
clinical depression
ADX71149
Addex
antidepressants
Headline:
J&J team marks another setback on depression as midstage study flops
Do Not Allow Advertisers to Use My Personal information
